Organization
SIFI
2 clinical trials
Clinical trial
Randomized, Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% PHMB Ophthalmic Solution in Comparison With 0.02% PHMB + 0.1% Propamidine Combination Therapy in Subjects Affected by Acanthamoeba KeratitisStatus: Completed, Estimated PCD: 2021-06-30
Clinical trial
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase II Study to Evaluate the Safety and Efficacy of Pro-ocular™ 0.5% and 1% in Patients With Dry Eye SyndromeStatus: Completed, Estimated PCD: 2022-10-27